Allergy/Asthma News

LEO Pharma presented full results from its long-term trial of Adbry for atopic dermatitis at the Fall Clinical Dermatology Conference, according to a company press release.

BOSTON — Patients with chronic spontaneous urticaria experienced significant improvements through 24 weeks with dupilumab, according to an abstract presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

BOSTON — Poor allergic rhinitis control was associated with an increase of depressive and anxiety symptoms, according to a poster presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

BOSTON — In 2021 vs. 1990, the prevalence of asthma declined in G20 countries, but asthma-related deaths rose, according to data presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

BOSTON — Among caregivers of children with asthma, only 54% were familiar with oral corticosteroid long-term side effects, according to a poster presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

BOSTON — Smokers with asthma were more likely to be prescribed a smoking cessation treatment than smokers who did not have asthma, according to a poster at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

Anaphylaxis protocols in emergency medical services have outdated recommendations and guidelines, according to an abstract presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

BOSTON — Chronic spontaneous urticaria symptoms improved with 1 week of remibrutinib treatment, according to a poster presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

BOSTON — Patients with hereditary angioedema saw significant reductions in attacks for 18 months after beginning berotralstat, according to two posters at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

BOSTON — Low-risk patients with syphilis and a penicillin allergy label should be delabeled to avoid treatment failure, according to a poster presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.